Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery
Public ClinicalTrials.gov record NCT02080689. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PROspective Study of the IMPACT of Decipher™ Prostate Cancer Classifier on Physician and Patient Treatment Consideration and Decisions Following Radical Prostatectomy [PRO-IMPACT]
Study identification
- NCT ID
- NCT02080689
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- GenomeDx Biosciences Corp
- Industry
- Enrollment
- 286 participants
Conditions and interventions
Conditions
Interventions
- Decipher Other
Other
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2014
- Primary completion
- Jan 31, 2017
- Completion
- Jan 31, 2017
- Last update posted
- Feb 26, 2017
2014 – 2017
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Urology Institute Alaska Clinical Research Center | Anchorage | Alaska | 99503 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| University of Colorado, Denver Medical Campus | Aurora | Colorado | 80045 | — |
| The Urology Center of Colorado | Denver | Colorado | 80211 | — |
| Urological Research Network | Hialeah | Florida | 33016 | — |
| Lakeland Regional Health Systems | Lakeland | Florida | 33805 | — |
| University of Miami Miller School of Medicine | Miami | Florida | 33101 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Spectrum Health Medical Group | Grand Rapids | Michigan | 49546 | — |
| Delaware Valley Urology, LLC | Voorhees Township | New Jersey | 08043 | — |
| Carolina Urology Partners | Gastonia | North Carolina | 28054 | — |
| Lancaster Urology | Lancaster | Pennsylvania | 17604 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Fox Chase Cancer Center | Philadelphia | Pennsylvania | 19111 | — |
| UT Southwestern Medical Center | Dallas | Texas | 753910-9110 | — |
| Huntsman Cancer Hospital | Salt Lake City | Utah | 84112 | — |
| University of Vermont Medical Center | Burlington | Vermont | 05401 | — |
| Virginia Urology | Richmond | Virginia | 23235 | — |
| University of Washington | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02080689, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02080689 live on ClinicalTrials.gov.